Madrigal Pharmaceuticals, Inc. · NASDAQ:MDGL
Brennan Daniel J. received 404 Madrigal Pharmaceuticals, Inc. shares as an award (Form 4)
Traded Jun 17, 2026 · Filed Jun 18, 2026
On Jun 17, 2026, Brennan Daniel J. (Director) received 404 Madrigal Pharmaceuticals, Inc. shares as an award, leaving 1,371 shares. Filed Jun 18, 2026 (Form 4).
- Awarded
- 404 shares
- Holding after
- 1,371 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 17, 2026 | Common Stock | Award | 404 | 1,371 | Direct |